prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, page 1 / 2. copy No. Examination: Histopathological examination. PESEL: Gender: F. Material: Multiple organ resection - left breast. Expected time of examination: up to 8 working days. Clinical diagnosis: Results of immunohistochemical examination: Estrogen receptors found in 75% of neoplastic cell nuclei. Progesterone receptors found in 10% of neoplastic. cell nuclei. HER2 protein stained with HercepTest™ by DAKO. Score = 2+, verification by the FISH method recommended. Macroscopic description: Left breast sized 17.8 x 11.3 x 4.8 cm removed with axillary tissues sized 9 x 5 x 3 cm. Weight 400 g. Skin flap. 21.7 x 9.2 cm in size. Tumour sized 3.9 x 6.6 x 2.8 cm found in the central part, placed 1.4 cm from the upper. edge, 0.9 cm from the base and 0.0 cm from the skin. Status after blopsy (test No. Microscopic description: Carcinoma lobulare invasivum (G2 acc. to Elston: 3+2+1; 0 mitoses /10 HPF diam. 0.55 mm) Infiltratio. carcinomatosa cutis et mammillae. Glandular tissue showing parenchyma atrophy. Invasive lesions are placed 0.1 cm from the base of the surgical specimen. Axillary lymph nodes: Metastases. carcinomatosae in lymphonodo (No XI/XIII). Histopathological diagnosis: (including test No. Ca rei nom alobulare invasivum mammae sinistrae. Invasive lobular carcinoma of the left breast. Metastases carcinomatosae in lymphonodis axillae (XI/XIII) Cancer metastases in axillary lymph nodes (XI/XIII). (NHG2, pT3, pN3a). Examination: Histopathological examination page 2 / 2. PESEL: Gender: F. Results of immunohistochemical examination: RESULT OF HER2/neu GENE AMPLIFICATION with the FISH method by Path Vysion HER2 DNA Probe Kit. HER-2 GENE AMPLIFICATION NOT FOUND.

expanded version (tokens=915) : 
 The breast pathology report reveals the following information:

Histological classification:
- Subtype LumA

Receptor status:
- Estrogen receptors found in 75% of neoplastic cell nuclei
- Progesterone receptors found in 10% of neoplastic cell nuclei
- HER2 protein stained with HercepTest™ by DAKO. Score = 2+, verification by the FISH method recommended, but HER-2 GENE AMPLIFICATION NOT FOUND.

Description of tumor:
- Carcinoma lobulare invasivum (G2 acc. to Elston: 3+2+1; 0 mitoses /10 HPF diam. 0.55 mm)
- Infiltratio carcinomatosa cutis et mammillae
- Invasive lesions are placed 0.1 cm from the base of the surgical specimen
- Tumor sized 3.9 x 6.6 x 2.8 cm found in the central part of the left breast, placed 1.4 cm from the upper edge, 0.9 cm from the base and 0.0 cm from the skin

Other findings:
- Parenchyma atrophy in glandular tissue
- Metastases carcinomatosae in lymphonodo (No XI/XIII), indicating cancer metastases in axillary lymph nodes (XI/XIII).

Histopathological diagnosis:
- Invasive lobular carcinoma of the left breast
- Cancer

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1045) : 
 Report: The left breast mass was found to be a 3.9 x 6.6 x 2.8 cm invasive lobular carcinoma (LumA subtype) with estrogen receptors in 75% and HER2 protein score of 2+. Parenchyma atrophy was observed and cancer metastases were found in axillary lymph nodes. HER-2 gene amplification was not detected.

